Turn Therapeutics (TTRX) Research & Development (2024 - 2026)
Turn Therapeutics (TTRX) posted quarterly Research & Development of $109434.0 for Q1 2026, up 1081.92% year-over-year from $9259.0 in Q1 2025, and up 74.6% quarter-over-quarter from $62678.0 in Q4 2025.
Turn Therapeutics (TTRX) Research & Development (2024 - 2026) Analysis & Trends
Turn Therapeutics' Research & Development history runs 3 years deep, the most recent figure standing at $109434.0 for Q1 2026.
- In Q1 2026, Research & Development rose 1081.92% year-over-year to $109434.0; the TTM figure through Mar 2026 stood at $340070.0 (changed N/A YoY), while the FY2025 annual figure was $265570.0, up 7.97% from the prior year.
- Research & Development for Q1 2026 stood at $109434.0, up from $62678.0 in the prior quarter.
- The five-year high for Research & Development was $158699.0 in Q3 2025, with the low at $9259.0 in Q1 2025.
- The 3-year median for Research & Development is $86056.0 (2025), against an average of $83853.0.
- The sharpest annual moves came in 2025 and 2026: Research & Development increased 3.53% in 2025, then jumped 1081.92% in 2026.
- Turn Therapeutics' Research & Development stood at $9766.0 in 2024, then jumped by 541.8% to $62678.0 in 2025, then soared by 74.6% to $109434.0 in 2026.
- Business Quant data shows TTRX's Research & Development at $109434.0 in Q1 2026, $62678.0 in Q4 2025, and $158699.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 993.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.63 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.37 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 394.92 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 612.28 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 1,146.05 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 97.90 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 413.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 210.03 Mn |
| 10 | Turn Therapeutics | 285.07 Mn | 285.07 Mn | - | 475,064.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 475,064.00 |
| Mar 31, 2026 | 109,434.00 |
| Dec 31, 2025 | 62,678.00 |
| Sep 30, 2025 | 158,699.00 |
| Mar 31, 2025 | 9,259.00 |
| Dec 31, 2024 | 9,766.00 |
| Sep 30, 2024 | 153,282.00 |